Ask AI
S. 4430

Interagency Patent Coordination and Improvement Act of 2022

Interagency Patent Coordination and Improvement Act of 2022

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.

Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.

Sen. Durbin, Richard J. [D-IL](D-IL)Sponsor
5 cosponsors2 D3 R
5cosponsors1committees6actions6subjects
  1. Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.

  2. Committee

    Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

    Judiciary Committee
  3. Committee14000

    Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

    Judiciary Committee
  4. Committee

    Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Judiciary Committee
  5. IntroReferral

    Read twice and referred to the Committee on the Judiciary.

    Judiciary Committee
  6. IntroReferral10000

    Introduced in Senate

Aug 2, 202225

Interagency Patent Coordination and Improvement Act of 2022

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.

Jun 16, 2022

Interagency Patent Coordination and Improvement Act of 2022

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.

Interagency Patent Coordination and Improvement Act of 2022 — Informed